Vireo GrowthVREOD -0.15%52 Days Inventory is 132.37 as of Mar. 2026, which is 20% below its 10-year median of 165.94. GuruFocus rates VREOD with a GF Score™ of 52/100 and a GF Value™ of $9.09 (Fairly Valued). The stock has 6 warning signs investors should review. Among 919 Drug Manufacturers companies, Vireo Growth ranks better than 72.47% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Vireo Growth's Average Total Inventories for the
three
months ended in Mar. 2026 was $68.0 Mil. Vireo Growth's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $46.9 Mil.
Hence, Vireo Growth's Days Inventory for the
three
months ended in Mar. 2026 was 132.37.
The historical rank and industry rank for Vireo Growth's Days Inventory or its related term are showing as below:
VREOD'
s Days Inventory Range Over the Past 10 Years
Min: 106.08 Med: 165.94 Max: 236.76
Current: 114.61
During the past 13 years, Vireo Growth's highest Days Inventory was 236.76. The lowest was 106.08. And the median was 165.94.
VREOD's Days Inventory is ranked better than 72.47% of 919
companies
in the Drug Manufacturers industry
Industry Median: 162.83
vs VREOD: 114.61
Vireo Growth's Days Inventory
declined
from Mar. 2025 (169.71) to Mar. 2026 (132.37).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vireo Growth's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.69.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vireo Growth's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.64.
Vireo Growth (OTCPK:VREOD) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vireo Growth's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vireo Growth's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vireo Growth Days Inventory Related Terms
Vireo Growth Days Inventory Historical Data
* Premium members only.
The historical data trend for Vireo Growth's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vireo Growth's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vireo Growth Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vireo Growth's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vireo Growth's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vireo Growth (VREOD) has a Days Inventory of 132.37 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vireo Growth and its competitors. This is 20% below median its historical median of 165.94. Over the past decade, Vireo Growth's Days Inventory has ranged from 106.08 to 236.76. According to the industry distribution chart, Vireo Growth ranks #253 out of 919 companies in the Drug Manufacturers industry, placing it in the top 27.5%.
Is Vireo Growth's Days Inventory too high?
Vireo Growth's current Days Inventory of 132.37 is 20% below median its 10-year median of 165.94. Over the past 10 years, this metric has ranged from a low of 106.08 to a high of 236.76. The Drug Manufacturers industry median Days Inventory is 162.83. Vireo Growth's value of 132.37 is 18.7% below this industry median. Based on the distribution chart, Vireo Growth ranks #253 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Vireo Growth has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Vireo Growth's Days Inventory compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vireo Growth ranks #253 out of 919 companies for Days Inventory. This puts Vireo Growth in the upper half of its industry. The industry median Days Inventory is 162.83. Vireo Growth's value of 132.37 is 18.7% below this benchmark. Historically, Vireo Growth's own Days Inventory has ranged from 106.08 to 236.76 over the past decade. While the company's 10-year median is 165.94 vs. the industry median of 162.83, Vireo Growth has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vireo Growth's current Days Inventory of 132.37 is 18.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vireo Growth and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vireo Growth's current Days Inventory is 132.37, which is 20% below median its own 10-year median of 165.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vireo Growth stock overvalued right now?
Based on GuruFocus' analysis, Vireo Growth (VREOD) is currently considered Fairly Valued. The stock's GF Value™ is $9.09, compared to a current price of $9.99 — trading 9.8% above its estimated fair value. The current Days Inventory is 132.37, which is 20% below median its 10-year median of 165.94 and 18.7% below the Drug Manufacturers industry median of 162.83. Vireo Growth's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vireo Growth (VREOD), the current Days Inventory is 132.37 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vireo Growth (VREOD) Overvalued in 2026?
Based on GuruFocus' analysis, Vireo Growth stock appears to be overvalued.
The current stock price of $9.99 is trading 9.8% above its estimated GF Value™ of $9.09.
GuruFocus considers Vireo Growth to be Fairly Valued.
Key valuation signals for VREOD:
Days Inventory: 132.37 (20% below median its 10-year median of 165.94)
GF Value™: $9.09 vs. price of $9.99 (9.8% above fair value)
Industry Position: 18.7% below the Drug Manufacturers median (#253 of 919)
No single metric tells the full story. See the VREOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vireo Growth Incis a cannabis company whose mission is to provide safe access, quality products and value to its customers while supporting its local communities through active participation and restorative justice programs. The Company is evolving with the industry and is in the midst of a transformation to being significantly more customer-centric across its operations, which include cultivation, manufacturing, wholesale and retail business lines. The company operates in one single segment.
52GF Score
Get the complete analysis for VREOD
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VREOD has been successfully added to your 
